Female reproductive tract pain: targets, challenges, and outcomes

Pain from the female reproductive tract (FRT) is a significant clinical problem for which there are few effective therapies. The complex neuroantomy of pelvic organs not only makes diagnosis of pelvic pain disorders difficult but represents a challenge to development of targeted therapies. A number...

Full description

Bibliographic Details
Main Authors: Phillip eJobling, Kate eO'Hara, Susan eHua
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-02-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00017/full
id doaj-9dc89f0799e14619a6e58c06d50f8ee3
record_format Article
spelling doaj-9dc89f0799e14619a6e58c06d50f8ee32020-11-24T22:33:33ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122014-02-01510.3389/fphar.2014.0001778375Female reproductive tract pain: targets, challenges, and outcomesPhillip eJobling0Kate eO'Hara1Susan eHua2University of NewcastleUniversity of NewcastleUniversity of NewcastlePain from the female reproductive tract (FRT) is a significant clinical problem for which there are few effective therapies. The complex neuroantomy of pelvic organs not only makes diagnosis of pelvic pain disorders difficult but represents a challenge to development of targeted therapies. A number of potential therapeutic targets have been identified on sensory neurons supplying the FRT but our knowledge on the basic neurophysiology of these neurons is limited compared with other viscera. Until this is addressed we can only guess if the new experimental therapies proposed for somatic, gastrointestinal or bladder pain will translate to the FRT. Once suitable therapeutic targets become clear, the next challenge is drug delivery. The FRT represents a promising system for topical drug delivery that could be tailored to act locally or systemically depending on formulation. Development of these therapies and their delivery systems will need to be done in concert with more robust in vivo and in vitro models of FRT pain.http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00017/fullPelvic PainUterusVaginaCervixdrug delivery.
collection DOAJ
language English
format Article
sources DOAJ
author Phillip eJobling
Kate eO'Hara
Susan eHua
spellingShingle Phillip eJobling
Kate eO'Hara
Susan eHua
Female reproductive tract pain: targets, challenges, and outcomes
Frontiers in Pharmacology
Pelvic Pain
Uterus
Vagina
Cervix
drug delivery.
author_facet Phillip eJobling
Kate eO'Hara
Susan eHua
author_sort Phillip eJobling
title Female reproductive tract pain: targets, challenges, and outcomes
title_short Female reproductive tract pain: targets, challenges, and outcomes
title_full Female reproductive tract pain: targets, challenges, and outcomes
title_fullStr Female reproductive tract pain: targets, challenges, and outcomes
title_full_unstemmed Female reproductive tract pain: targets, challenges, and outcomes
title_sort female reproductive tract pain: targets, challenges, and outcomes
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2014-02-01
description Pain from the female reproductive tract (FRT) is a significant clinical problem for which there are few effective therapies. The complex neuroantomy of pelvic organs not only makes diagnosis of pelvic pain disorders difficult but represents a challenge to development of targeted therapies. A number of potential therapeutic targets have been identified on sensory neurons supplying the FRT but our knowledge on the basic neurophysiology of these neurons is limited compared with other viscera. Until this is addressed we can only guess if the new experimental therapies proposed for somatic, gastrointestinal or bladder pain will translate to the FRT. Once suitable therapeutic targets become clear, the next challenge is drug delivery. The FRT represents a promising system for topical drug delivery that could be tailored to act locally or systemically depending on formulation. Development of these therapies and their delivery systems will need to be done in concert with more robust in vivo and in vitro models of FRT pain.
topic Pelvic Pain
Uterus
Vagina
Cervix
drug delivery.
url http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00017/full
work_keys_str_mv AT phillipejobling femalereproductivetractpaintargetschallengesandoutcomes
AT kateeohara femalereproductivetractpaintargetschallengesandoutcomes
AT susanehua femalereproductivetractpaintargetschallengesandoutcomes
_version_ 1725730461450240000